Search Results

69,489 Results for "actelion ltd".

Sort By

Press Releases

BlackfinBio Ltd announces the acquisition of Parkinson’s IP patent portfolio from OXB

January 8, 2025
·
1 min read
Press Releases

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

December 24, 2024
·
8 min read
Press Releases

WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024

November 28, 2024
·
4 min read
Press Releases

AI/ML Innovations to Acquire Quantum Sciences Ltd

December 10, 2024
·
4 min read
Press Releases

Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd

December 18, 2024
·
4 min read
Press Releases

Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan

December 25, 2024
·
1 min read
Press Releases

Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering

December 31, 2024
·
4 min read
Deals

Juvisé Pharmaceuticals Acquires Multiple Sclerosis Drug PONVORY® (ex-US/Canada) and Opens Its Capital to Bpifrance and Pemberton

The French pharmaceutical company, Juvisé Pharmaceuticals, announces the acquisition of global commercial rights (excluding the United States and Canada) to Ponvory® (ponesimod) from Actelion Pharmaceuticals Ltd., a Johnson & Johnson Company (Johnson & Johnson). Ponvory® is indicated for the treatment of adults with active forms of relapsing multiple sclerosis (RMS); it is protected by several patents, the latest of which expires in 2035.

March 26, 2024
·
4 min read
Press Releases

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

December 11, 2024
·
3 min read
Press Releases

Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering

December 26, 2024
·
4 min read